G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%
Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021
Accelerating growth strategy with expansion of Prizma and Cardiac sales team
UnityPoint Prizma vital signs pilot study to start end of September; new cardiac services program underway